Advanced Proteome Therapeutics Updates its Activities During the 3rd Quarter, FY 2018
01 mai 2018 08h30 HE
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, British Columbia, May 01, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV:APC) (FSE:0E8) is pleased to provide an update of progress...
Advanced Proteome Therapeutics Announces Appointment of Scientific Advisory Board Members
24 avr. 2018 08h30 HE
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, British Columbia, April 24, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV:APC) (FSE:0E8) is pleased to announce the appointments of...
Advanced Proteome Therapeutics Announces Appointment of New Board Members
16 avr. 2018 17h04 HE
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV:APC) (FSE:0E8) is pleased to announce the appointments of...
Advanced Proteome Therapeutics Announces CEO and Director Resignations
16 avr. 2018 08h00 HE
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSX-V:APC) (FSE:0E8) announces that its Board of Directors has...
Advanced Proteome Therapeutics and ImmunoBiochem Corporation enter into a Collaboration and Option Agreement
07 févr. 2018 08h30 HE
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, British Columbia and TORONTO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (APC), a therapeutics discovery and development company, and ImmunoBiochem...
Advanced Proteome Therapeutics Announces New Patent Grant
05 févr. 2018 08h00 HE
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - February 05, 2018) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to announce that the Japanese...
Advanced Proteome Therapeutics Announces Anti-Cancer R&D Gathers Momentum
31 janv. 2018 08h00 HE
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - January 31, 2018) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) announces that during the 2017 calendar year,...
Advanced Proteome Therapeutics and Heidelberg Pharma Progress Collaborative Program
08 janv. 2018 08h30 HE
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC and LADENBURG, GERMANY--(Marketwired - January 08, 2018) - Advanced Proteome Therapeutics Corporation (APC), a therapeutics discovery and development company, and Heidelberg Pharma...
Advanced Proteome Therapeutics Expands Antibody-Drug Conjugate Collaboration
20 nov. 2017 08h00 HE
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - November 20, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) a biotechnology company focused on...
Advanced Proteome Therapeutics Announces Formation of Business Advisory Committee
15 nov. 2017 08h00 HE
|
Advanced Proteome Therapeutics Corporation
VANCOUVER, BC--(Marketwired - November 15, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8), announced today that it has formed an...